Please do not adjust margins
ChemComm
Page 4 of 4
COMMUNICATION
Journal Name
To demonstrate the synthetic power of the present protocol,
we embarked on to apply it in the formal synthesis of an
intermediate of Merck’s clinical agent MK-7246 (Scheme 7),
which is a potent and selective CRTH2 [chemo-attractant
receptor expressed on T helper type 2 (Th2) cells] antagonist,
for the treatment of respiratory diseases.16 Initially, to prove
the practicality of the present one-pot sequential method, we
carried out a multi-gram scale reaction of 1b and 2a to afford
the representative 2-alkenyl-3-indole acetate 5b in high yield
(Scheme 7). The indole 5b was subjected to palladium-
catalyzed hydrogenation to effect the reduction of the exo-
alkenyl moiety of 5b to give 7. The compound 7 was treated
with t-butyl bromoacetate to give the corresponding N-
alkylated intermediate 8 (Scheme 7). The agent MK-7246 can
formally be synthesized from 8 using the literature reports.16
In summary, we have presented an unprecedented strategy
involving intra-VMA–elimination–aromatization cascade for
the construction of indoles. The one-pot sequential
transformation based on the base-mediated N-allylation
followed by intra-VMA–elimination–aromatization cascade
DOI: 10.1039/D0CC06564A
K. Yum and M. D. Refvik, J. Org. Chem., 1998, 63, 7652; (d) Y.
Chen, X. Xie and D. Ma, J. Org. Chem., 2007, 72, 9329.
For selected papers on the chemistry and biology 2-vinyl
substituted indoles, see: (a) K. Bera and C. Schneider, Chem.
Eur. J., 2016, 22, 7074; (b) J.-J. Zhao, S.-B. Sun, S.-H. He, Q.
Wu and F. Shi, Angew. Chem. Int. Ed., 2015, 54, 5460; (c) J.-J.
Zhao, M. Tang, H.-H. Zhang, M.-M. Xu and F. Shi, Chem.
Commun., 2016, 52, 5953; (d) T. J. H. Arends and J. A. Witjes
Urol. Clin. North Am., 2020, 47, 73; (e) G. L. Plosker and A. J.
Wagstaff, Drugs 1996, 51, 433; (f) D. H. Dethe, R. D. Erande
and A. Ranjan, J. Am. Chem. Soc. 2011, 133, 2864.
For selected examples on C-2 functionalization of indoles to
2-vinyl indoles, see: (a) V. Lanke and K. R. Prabhu, Org. Lett.
2013, 15, 2818; (b) S. Sharma, S. Han, M. Kim, N. K. Mishra, J.
Park, Y. Shin, J. Ha, J. H. Kwak, Y. H. Junga and I. S. Kim, Org.
Biomol. Chem. 2014, 12, 1703; (c) A. García-Rubia, R. G.
Arrayás and J. C. Carretero, Angew. Chem. Int. Ed. 2009, 48,
6511.
5
6
7
For cross-coupling of indoles and alkenyl partners, see: (a) T.
Fukuyama, X. Chen and G. Peng, J. Am. Chem. Soc. 1994, 116,
3127; (b) H. Tokuyama, Y. Kaburagi, X. Chen and T.
Fukuyama, Synthesis 2000, 3, 429; (c) M. Tobisu, H. Fujihara,
K. Koh and N. Chatani, J. Org. Chem. 2010, 75, 4841.
A. S. Makarov, M. G. Uchuskin and V. Gevorgyan, J. Org.
Chem. 2018, 83, 14010.
using
o-tosylamidocinnamates/congeners
and
γ-
8
9
bromocrotonates has been described for the synthesis of 2-
alkenyl indole derivatives in reasonable to high yields. The
synthesis of 2-alkenyl indole derivatives has been
accomplished using a one-pot, transition metal-free process.
The present one-pot protocol has been demonstrated in the
formal synthesis of selective CRTH2 antagonist MK-7246, a
Merck’s clinical agent. Further explorations on the intra-VMA
chemistry and its applications are in progress in our laboratory.
We thank the Science & Engineering Research Board (SERB),
Department of Science and Technology (DST), India for an
Extra-mural Research grant (EMR/2017/002601). BH and SY
thank CSIR, New Delhi, for fellowships. We thank the Director,
H.-A. Seo and C.-H. Cheon, J. Org. Chem. 2016, 81, 7917.
10 B. Harish, M. Subbireddy and S. Suresh, Chem. Commun.
2017, 53, 3338.
11 For an excellent recent review on vinylogous concept, see:
(a) C. Curti, L. Battistini, A. Sartori and F. Zanardi, Chem. Rev.
2020, 120, 5, 2448 and references cited therein; (b) O.
Obulesu, J. B. Nanubolu and S. Suresh, Org. Biomol. Chem.
2015, 13, 8232; (c) O. Obulesu, V. Murugesh, B. Harish and S.
Suresh, J. Org. Chem. 2018, 83, 6454.
12 (a) I. D. Jurberg, I. Chatterjee, R. Tannert and P. Melchiorre,
Chem. Commun. 2013, 49, 4869; (b) X. Jusseau, L. Chabaud
and C. Guillou, Tetrahedron 2014, 70, 2595; (c) C. Schneider
and F. Abels, Org. Biomol. Chem. 2014, 12, 3531; (d) H. B.
Hepburn, L. Dell’Amico and P. Melchiorre, Chem. Rec. 2016,
16, 1787; (e) Y. Yin and Z. Jiang, ChemCatChem 2017, 9,
4306.
CSIR-IICT
for
the
support
(communication
No.
IICT/Pubs./2020/143).
13 (a) K. Clinch, C. J. Marquez, M. J. Parrotta and R. Ramage,
Tetrahedron 1989, 45, 239; (b) S. Nara, H. Toshlma and A.
Ichihara, Tetrahedron Lett. 1996, 37, 6745; (c) D. Gray and T.
Gallagher, Angew. Chem. Int. Ed. 2006, 45, 2419; (d) T.
Gallagher, I. Derrick, P. M. Durkin, C. A. Haseler, C.
Hirschhauser and P. Magrone, J. Org. Chem. 2010, 75, 3766;
(e) K. Lee, H. Kim and J. Hong, Angew. Chem. Int. Ed. 2012,
51, 5735; (f) R. M. de Figueiredo, R. Fröhlich and M.
Christmann, Angew. Chem. Int. Ed. 2008, 47, 1450; (g) Z.-Y.
Wang, W.-T. Wong and D. Yang, Org. Lett. 2013, 15, 4980;
For a very recent example, see: (h) D. Li, Y. Yang, M. Zhang, L.
Wang, Y. Xu, D. Yang and R. Wang, Nat. Commun. 2020, 11,
Article number: 2559.
14 B. Harish, M. Subbireddy, O. Obulesu and S. Suresh, Org.
Lett. 2019, 21, 1823.
15 (a) R. W. D. Simone, K. S. Currie, S. A. Mitchell, J. W. Darrow
and D. A. Pippin, Comb. Chem. High Throughput Screen.
2004, 7, 473; (b) L. Yet, Privileged Structures in Drug
Discovery: Medicinal Chemistry and Synthesis; Willey:
Hoboken, 2018.
Notes and references
1
2
(a) R. J. Sundberg, Indoles; Academic Press: San Diego, 1996;
(b) J. A. Joule and K. Mills, Heterocyclic Chemistry; Blackwell
Science: Oxford, UK, 2000; (c) G. R. Humphrey and J. T.
Kuethe, Chem. Rev. 2006, 106, 2875 and references cited
therein; (d) G. W. Gribble, Indole Ring Synthesis: From
Natural Products to Drug Discovery; John Wiley: West
Sussex, 2016.
(a) A. J. Kochanowska-Karamyan and M. T. Hamann, Chem.
Rev., 2010, 110, 4489; (b) N. K. Kaushik, N. Kaushik, P. Attri,
N. Kumar, C. H. Kim, A. K. Verma and E. H. Choi, Molecules,
2013, 18, 6620 and references cited therein; (c) E. Vitaku, D.
T. Smith and J. T. Njardarson, J. Med. Chem., 2014, 57,
10257; (d) N. Chadha and O. Silakari, Eur. J. Med. Chem.,
2017, 134, 159 and references cited therein.
3
4
(a) L. Kürti and B. Czakó, Strategic Applications of Named
Reactions in Organic Synthesis; Elsevier Academic Press:
London, 2005; (b) J. J. Li, Named Reactions: A Collection of
Detailed Mechanisms and Synthetic Applications; Springer:
Berlin, 2006; (c) M. Inman and C. J. Moody, Chem. Sci., 2013,
4, 29.
16 C. Molinaro, P. G. Bulger, E. E. Lee, B. Kosjek, S. Lau, D.
Gauvreau, M. E. Howard, D. J. Wallace and P. D. O’Shea, J.
Org. Chem. 2012, 77, 2299 and references cited therein.
For selected reviews on 2,3-disubstituted indoles, see: (a) S.
Cacchi and G. Fabrizi, Chem. Rev., 2011, 111, PR215; (b) Y.
4 | J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins